State Ledger
Company profile

AEON Biopharma, Inc. CIK 1837607

Ticker
AEON (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Aliso Viejo, CA 92656
Fiscal year end
2025 (FY)
Market Data
Close
$0.28
Change
-$0.03
Change %
-10.11%
Volume
13,627

AEON · trading date Oct 9, 2026 · previous close $0.31 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$39.22M
Total assets
$5.56M
Total liabilities
$60.59M
Stockholders' equity
-$55.03M
Cash & equivalents
$3.01M
Operating income
-$12.80M
Operating cash flow
-$17.31M
Capital expenditures
$4.0K

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$17.31M
Free cash flow margin
—
Liabilities / assets
1,089.7%
Equity / assets
-989.7%
CapEx / revenue
—
Operating cash flow / net income
0.44×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$39.22M $5.56M $60.59M -$55.03M
2024 — $42.01M $3.14M $31.71M -$28.57M
2023 — — $6.85M $159.89M -$153.04M
2022 — -$52.56M $10.78M $143.24M -$287.50M
2021 — $8.20M $276.95M $17.88M -$16.93M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form SCHEDULE 13G
2026-08-21
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Aliso Viejo, CA 92656
130 VANTIS DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:19 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies